SCHEMBL8992298

SCHEMBL8992298

CC(C)(C)NC1CCC(c2ccccc2)(c2ccccc2)C1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 6/20 0.41
GRIN2D O15399 1/20 0.41
GRIN3B O60391 1/20 0.41
CHRM2 P08172 1/20 0.41
CHRM1 P11229 1/20 0.41
GRIN1 Q05586 1/20 0.41
KCNH2 Q12809 1/20 0.41
GRIN2A Q12879 1/20 0.41
GRIN2B Q13224 1/20 0.41
GRIN2C Q14957 1/20 0.41
GRIN3A Q8TCU5 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
ALOX15 P16050 1/20 0.39
OPRL1 P41146 3/20 0.37
ALDH1A1 P00352 1/20 0.36
DRD4 P21917 1/20 0.35
KDM1A O60341 2/20 0.35
MAOB P27338 1/20 0.35
MAOA P21397 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9586032 0.91 ALOX15 (0.40) OPRM1GRIN2DGRIN3BCHRM2CHRM1
SCHEMBL8992487 0.90 OPRM1 (0.47) OPRM1GRIN2DGRIN3BCHRM2CHRM1
SCHEMBL9587286 0.86 OPRM1 (0.42) OPRM1GRIN2DGRIN3BCHRM2CHRM1
SCHEMBL9585212 0.81 OPRM1 (0.41) OPRM1GRIN2DGRIN3BCHRM2CHRM1
SCHEMBL11763463 0.81 MAPK1 (0.44) OPRM1MAPK1SMN1; SMN2ALOX15OPRL1
SCHEMBL9586402 0.78 ALDH1A1 (0.37) OPRM1GRIN2DGRIN3BCHRM2CHRM1
SCHEMBL11765784 0.73 KDM1A (0.41) MAPK1SMN1; SMN2ALOX15KDM1A
SCHEMBL2019808 0.69 MAPK1 (0.46) OPRM1MAPK1SMN1; SMN2DRD4
SCHEMBL9807220 0.69 OPRM1 (0.52) OPRM1GRIN2DGRIN3BCHRM2CHRM1
Pramiverine SCHEMBL24038 0.69 GAA (0.47) OPRM1GRIN2DGRIN3BCHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0445749-B1 N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments FUJISAWA PHARMACEUTICAL CO (JP) 1996-07-10 EP disclosed
US-5256824-A Anticholinergic agents FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1993-10-26 US disclosed
EP-0445749-A1 N-Monosubstituted cyclopentenylamines, a process for their preparation and their use as medicaments FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1991-09-11 EP disclosed